The 5 most recent market catalysts affecting $NIVF, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 5, 2026
Corporate Catalyst
Bearish
Impact 75
NewGenIVF Group shares are trading lower after the company disclosed its outstanding Class A share count following a recent offering, note conversions, and equity line issuances.
The disclosure of an increased Class A share count for NewGenIVF Group is a significant corporate catalyst. This typically leads to dilution for existing shareholders, as the compa…
Oct 2, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Friday's Pre-Market Session
This 8-K filing highlights pre-market trading activity for several health care stocks, indicating short-term volatility. The significant percentage changes, both positive and negat…
Oct 2, 2026
Corporate Catalyst
Bullish
Impact 75
NewGenIvf (NIVF) Stock Soars Over 28% After-Hours: What's Driving the Surge?
NewGenIvf Group Ltd (NIVF) successfully closed a 'reasonable best efforts' public offering, generating $1.25 million in gross proceeds. This capital raise, while modest, is a signi…
Jul 30, 2026
Corporate Catalyst
Neutral
Impact 65
NewGenIVF Announces Its 13% Stake In K25.ai Is Now Valued At ~$26M, Generating Expected Unrealized Gain Of ~$8.5M
NewGenIVF (NIVF) has disclosed a significant appreciation in its 13% stake in K25.ai, with the investment now valued at $26 million, leading to an $8.5 million expected unrealized …
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 65
NewGenIVF Group Agrees To Acquire Additional 3% Equity Interest In K25.Ai At $250M Equity Valuation
NewGenIVF Group (NIVF) is acquiring an additional 3% equity interest in K25.ai for $7.5 million, raising its total stake to 13%. This transaction values K25.ai at $250 million, ref…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.